Effect of sesame oil on the inhibition of experimental autoimmune encephalomyelitis in C57BL/6 mice

Pakistan Journal of Biological Sciences

Volumn 10, Issue 11, 2007, Pages 1790-1796

  Mosayebi, G ^a   Ghazavi, A ^a   Salehi, H ^a   Payani, M A ^a   Khazaei, M R ^a  

^a ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Experimental autoimmune encephalomyelitis; Multiple sclerosis; Nitric oxide; Sesame oil; Total antioxidant capacity

Indexed keywords

MUS; SESAMUM INDICUM;

EID: 34247186907     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2007.1790.1796     Document Type: Article

References (35)

1. Akimoto, K., Y. Kitagawa, T. Akamatsu, N. Hirose, M. Sugano, S. Shimizu and H. Yamada, 1993. Protective effects of sesamin against liver damage caused by alcohol or carbon tetrachloride in rodents. Ann. Nutr. Metab., 37: 218-224.
2. Aniya, Y., T. Koyama, C. Miyagi, M. Miyahira, C. Inomata, S. Kinoshita and T. Ichiba, 2005. Free radical scavenging and hepatoprotective actions of the medicinal herb, Crassocephalum crepidioides from the Okinawa Islands. Biol. Pharm. Bull., 28: 19-23.
3. Benzie, I.F. and J.J. Strain, 1996. The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: The FRAP assay. Anal. Biochem., 239: 70-76.
4. Chavali, S.R., T. Utsunomiya and R.A. Forse, 2001. Increased survival after cecal ligation and puncture in mice consuming diets enriched with sesame seed oil. Crit. Care Med., 29: 140-143.
5. Clegg, A. and J. Bryant, 2001. Immunomodulatory drugs for multiple sclerosis: A systematic review of clinical and cost effectiveness. Exp. Opin. Pharmacother., 2: 623-639.
6. Costa, O., D. Divoux, A. Ischenko, F. Tron and M. Fontaine, 2003. Optimization of an animal model of experimental autoimmune encephalomyelitis achieved with a multiple MOG (35-55) peptide in C57BL6/J strain of mice. J. Autoimmun, 20: 51-61.
7. Dalton, D.K. and S. Wittmer, 2005. Nitric-oxide-dependent and independent mechanisms of protection from CNS inflammation during Th1-mediated autoimmunity: Evidence from EAE in iNOS KO mice. J. Neuroimmunol., 160: 110-121.
8. Dean, G., 1994. How many people in the world have multiple sclerosis? Neuroepidemiol., 13: 1-7.
9. Donoghue, S. and C. Greenlees, 2000. Drugs in development for the treatment of multiple sclerosis: Antigen non-specific therapies-an update. Exp. Opin. Investig. Drugs., 9: 167-171.
10. Gold, R., H.P. Hartung, K.V. Toyka, 2000. Animal models for autoimmune demyelinating disorders of the nervous system. Mol. Med. Today, 6: 88-91.
11. Hogg, N., 1995. Pro-oxidant and antioxidant effects of nitric oxide. In: Favier, A.E., J. Cadet, B. Kalyanaraman, M. Fontecave and J.L. Pierre, 1995. Analysis of free radicals in biological systems. Brikhauser vertag, Basel, pp: 37-49.
12. Hou, R.C., H.L. Chen, J.T. Tzen and K.C Jeng, 2003. Effect of sesame antioxidants on LPS-induced NO production by BV2 microglial cells. Neuroreport, 14: 1815-1819.
13. Hsu, D.Z. and M.Y. Liu, 2002. Sesame oil attenuates multiple organ failure and increases survival rate during endotoxemia in rats. Crit. Care Med., 30: 1859-1862.
14. Hsu, D.Z., Y.H. Li, S.P. Chien and M.Y. Liu, 2004. Effects of sesame oil on oxidative stress and hepatic injury after cecal ligation and puncture in rats. Shock, 21: 466-469.
15. Hsu, D.Z., S.B. Su, S.P. Chien, P.J. Chiang, Y.H. Li, Y.J. Lo and M.Y. Liu, 2005. Effect of sesame oil on oxidative-stress-associated renal injury in endotoxemic rats: Involvement of nitric oxide and proinflammatory cytokines. Shock, 24: 276-280.
16. Hunter, M.I., B.C. Nlemadim and D.L. Davidson, 1985. Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients. Neurochem. Res., 10: 1645-1652.
17. Kang, M.H., M. Naito, N. Tsujihara and T. Osawa, 1998. Sesamolin inhibits lipid peroxidation in rat liver and kidney. J. Nutr., 128: 1018-1022.
18. Kayhan, B., R. Aharoni and R. Arnon, 2003. Glatiramer acetate (Copaxone) regulates nitric oxide and related cytokine secretion in experimental autoimmune encephalomyelitis. Immunol. Lett., 88: 185-192.
19. LeVine, S.M., 1992. The role of reactive oxygen species in the pathogenesis of multiple sclerosis. Med. Hypotheses, 39: 271-274.
20. MacMicking, J.D., D.O. Willenborg, M.J. Weidemann, K.A. Rockett and W.B. Cowden, 1992. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells. J. Exp. Med., 176: 303-307.
21. Mosayebi, G., S.M. Moazzeni and M.H. Sanati, 2006. Effect of sex on susceptibility to experimental autoimmune encephalomyelitis induced with MOG35-55 peptide in C57BL/6 mice. Med. J. Tabriz, 27: 95-100.
22. Murphy, P., A. Sharp, J. Shin, V. Gavrilyuk, C. Dello Russo, G. Weinberg, F.R. Sharp, A. Lu, M.T. Heneka and D.L. Feinstein, 2002. Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis. J. Neurosci. Res., 67: 461-470.
23. Naidoo, R. and M.L. Knapp, 1992. Studies of lipid peroxidation products in cerebrospinal fluid and serum in multiple sclerosis and other conditions. Clin. Chem., 38: 2449-2454.
24. Nazliel, B., D. Taskiran, C. Irkec, F.Z. Kutay and S. Pogun, 2002. Serum nitric oxide metabolites in patients with multiple sclerosis. J. Clin. Neurosci., 9: 530-532.
25. Okuda, Y., Y. Nakatsuji, H. Fujimura, H. Esumi, T. Ogura, T. Yanagihara and S. Sakoda, 1995. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J. Neuroimmunol., 62: 103-112.
26. Okuda, Y., M. Okuda and C.C. Bernard, 2002. Gender does not influence the susceptibility of C57BL/6 mice to develop chronic experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein. Immunol. Lett., 81: 25-29.
27. Owens, T. and S. Sriram, 1995. The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis. Neurol. Clin., 13: 51-73.
28. Ramesh, B., R. Saravanan and K.V. Pugalendi, 2005. Influence of sesame oil on blood glucose, lipid peroxidation and antioxidant status in streptozotocin diabetic rats. J. Med. Food., 8: 377-381.
29. Salem, M.L., 2005. Systemic treatment with n-6 polyunsaturated fatty acids attenuates EL4 thymoma growth and metastasis through enhancing specific and non-specific anti-tumor cytolytic activities and production of TH1 cytokines. Int. Immunopharmacol., 5: 947-960.
30. Sherman, M.P., J.M. Griscavage and L.J. Ignarro, 1992. Nitric oxide-mediated neuronal injury in multiple sclerosis. Med. Hypotheses, 39: 143-146.
31. Staykova, M.A., J.T. Paridaen, W.B. Cowden and D.O. Willenborg, 2005. Nitric oxide contributes to resistance of the Brown Norway rat to experimental autoimmune encephalomyelitis. Am. J. Pathol., 166: 147-157.
32. Staykova, M.A., S.A. Fordham, G.J. Baiteli, W.B. Cowden and D.O. Willenborg, 2006. Nitric oxide contributes to the resistance of young SJL/J mice to experimental autoimmune encephalomyelitis. J. Neuroimmunol., 176: 1-8.
33. Teixeira, S.A., A.A. Varriano, A.A. Dias, R. Martins Porto and M.N. Muscara, 2005. Nitric oxide synthase activity and endogenous inhibitors in rats recovered from allergic encephalomyelitis. Mem. Inst. Oswaldo. Cruz., 1:25-27.
34. Willenborg, D.O., M.A. Staykova and W.B. Cowden, 1991. Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis. J. Neuroimmunol., 100: 21-35.
35. Yuceyar, N., D. Taskiran and A. Sagduyu, 2001. Serum and cerebrospinal fluid nitrite and nitrate levels in relapsing-remitting and secondary progressive multiple sclerosis patients. Clin. Neurol. Neurosurg., 103: 206-211.